SARS-CoV-2 RBD Neutralization Antibody (R323IgM)
SARS-CoV-2 RBD Neutralization Antibody (R323IgM)
V80302 | |
|
|
询价 | |
|
|
|
|
联系我们 |
V80302 | |
|
|
询价 | |
|
|
|
|
联系我们 |
SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. Neutralizing antibodies against SARS-CoV-2 can block the interaction between SARS-CoV-2 RBD and ACE2. It can be used in the assessment and development of assays for the detection and quantitation of SARS-CoV-2 neutralizing antibodies. |
Specificity | SARS-CoV-2 Spike Protein S1 subunit and its RBD domain |
Production |
|
|
Purification | Affinity chromatography |
|
Formulation | PBS, pH 7.2, containing 0.02% sodium azide. |
|
Concentration | ≥ 2 mg/ml |
|
Clone ID | R323IgM |
Target Background | SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. Neutralizing antibodies against SARS-CoV-2 can block the interaction between SARS-CoV-2 RBD and ACE2. It can be used in the assessment and development of assays for the detection and quantitation of SARS-CoV-2 neutralizing antibodies. |